Gutshall D M, Pilcher G D, Langley A E
Department of Pharmacology and Toxicology, Wright State University, School of Medicine, Dayton, Ohio 45435.
J Toxicol Environ Health. 1988;24(4):491-8. doi: 10.1080/15287398809531179.
The effects of thyroxine (T4) supplementation on perfluoro-n-decanoic acid- (PFDA) induced decreases in food consumption, body weight, and body temperature were examined. A dose-response study was carried out with 50-, 100-, 200-, or 250-micrograms/kg ip doses of T4 for 7 d prior to PFDA administration, and daily dosing with T4 was continued for an additional 30 d. From this study a T4 dose of 200 micrograms/kg was chosen, and subsequent experiments were conducted with this dose. Supplementation with T4 at 200 micrograms/kg daily alleviated the hypophagia but not the severe weight loss and hypothermia produced by PFDA treatment. Our results suggest that some component of the thyroid axis plays a role in feeding behavior. In addition, the PFDA-induced wasting syndrome and hypothermia appear to be unrelated to changes in serum thyroid hormones. The unexpected observation that severe weight loss occurred in the presence of essentially normal food intake suggests that PFDA alters basic cellular metabolic processes.
研究了补充甲状腺素(T4)对全氟正癸酸(PFDA)引起的食物摄入量、体重和体温下降的影响。在给予PFDA前7天,以50、100、200或250微克/千克的腹腔注射剂量对T4进行剂量反应研究,并继续每日给予T4额外30天。从该研究中选择了200微克/千克的T4剂量,并使用该剂量进行后续实验。每天补充200微克/千克的T4可减轻PFDA治疗引起的食欲减退,但不能减轻严重的体重减轻和体温过低。我们的结果表明,甲状腺轴的某些成分在摄食行为中起作用。此外,PFDA诱导的消瘦综合征和体温过低似乎与血清甲状腺激素的变化无关。在食物摄入量基本正常的情况下出现严重体重减轻这一意外观察结果表明,PFDA改变了基本的细胞代谢过程。